During the past decade, University of Nevada School of Medicine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 13 clinical trials were completed, i.e. on average, 325% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Nevada School of Medicine" #1 sponsor was "Pfizer" with 4 trials, followed by "Alzheimer's Disease Cooperative Study (ADCS)" with 2 trials sponsored, "Eisai Inc." with 2 trials sponsored, "Genzyme, a Sanofi Company" with 2 trials sponsored and "Knopp Biosciences" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Nevada School of Medicine" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Michael J. Fox Foundation for Parkinson's Research" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator and "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "University of Nevada School of Medicine" are "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (3 trials), "Parkinson's Disease" (3 trials), "Amyotrophic Lateral Sclerosis" (2 trials) and "Multiple Sclerosis, Relapsing-Remitting" (2 trials). Many other conditions were trialed in "University of Nevada School of Medicine" in a lesser frequency.

Most popular intervention types in "University of Nevada School of Medicine" are "Drug" (14 trials), "Biological" (6 trials), "Other" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Dexpramipexole" (2 trials), "Interferon beta-1a" (2 trials), "2 mg perampanel" (1 trials) and "225mg SHP647 (PF-00547659)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Nevada School of Medicine" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Nevada School of Medicine". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in University of Nevada School of Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Nevada School of Medicine, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".